We are live on ! Find out more
DPLO

DIPLOMAT PHARMACY, INC.
DPLO

Delisted

DPLO was delisted on the 7th of February, 2020.

Back to rankings

137 hedge funds and large institutions have $317M invested in DIPLOMAT PHARMACY, INC. in 2019 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 51 increasing their positions, 35 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

848% more call options, than puts

Call options by funds: $3.33M | Put options by funds: $351K

46% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 35

35% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 17

5% more funds holding

Funds holding: 131 → 137 (+6)

19% less capital invested

Capital invested by funds: $391M → $317M (-$73.6M)

Holders
137
Holders Change
+6
Holders Change %
+4.58%
% of All Funds
3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
51
Reduced
35
Closed
17
Calls
$3.33M
Puts
$351K
Net Calls
+$2.98M
Net Calls Change
+$4.65M

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$12.3M
2
Millennium Management
Millennium Management
New York
+$8.08M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$6.24M
4
JP Morgan Chase
JP Morgan Chase
New York
+$4.26M
5
UBS Group
UBS Group
Switzerland
+$2.43M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$22.6M
2
Capital World Investors
Capital World Investors
California
-$9.18M
3
Deutsche Bank
Deutsche Bank
Germany
-$3.08M
4
FCM
Frontier Capital Management
Massachusetts
-$2.12M
5
Invesco
Invesco
Georgia
-$1.17M
Name Holding Trade Value Shares
Change 		Change in
Stake
MOACM
126
Mutual of America Capital Management
New York
$10K +$560 +100 +5%
LIA
127
LS Investment Advisors
Michigan
$9K – – –
CFD
128
Creative Financial Designs
Indiana
$4K – – –
CFGS
129
Concourse Financial Group Securities
Alabama
$1K – – –
SB
130
Strategic Blueprint
Georgia
$1K +$739 +132 New
TFO
131
Tarbox Family Office
California
$1K +$1.01K +181 +266%
PA
132
Parallel Advisors
California
$1K +$1.54K +276 New
APA
133
American Portfolios Advisors
New York
$706 – – –
GT
134
Glenmede Trust
Pennsylvania
$2 +$1.5K +268 +176%
Canada Life
135
Canada Life
Manitoba, Canada
– -$456K -75,187 Closed
ARTA
136
A.R.T. Advisors
New York
– -$433K -71,140 Closed
MWNA
137
Marshall Wace North America
New York
– -$407K -66,836 Closed
Voloridge Investment Management
138
Voloridge Investment Management
Florida
– -$359K -58,876 Closed
GCP
139
GSA Capital Partners
United Kingdom
– -$192K -31,584 Closed
Nomura Holdings
140
Nomura Holdings
Japan
– -$178K -30,000 Closed
EMG
141
Ellington Management Group
Connecticut
– -$129K -21,200 Closed
WCM
142
Weld Capital Management
New York
– -$121K -19,890 Closed
TI
143
Trexquant Investment
Connecticut
– -$103K -16,924 Closed
Norges Bank
144
Norges Bank
Norway
– -$69K -11,399 Closed
Wolverine Trading
145
Wolverine Trading
Illinois
– -$64K -10,573 Closed
PCM
146
Prelude Capital Management
New York
– -$13K -2,066 Closed
PCP
147
Proficio Capital Partners
Massachusetts
– -$6K -954 Closed
RIA
148
Realta Investment Advisors
Delaware
– -$1K -225 Closed
US Bancorp
149
US Bancorp
Minnesota
– -$1K -212 Closed
TRCT
150
Tower Research Capital (TRC)
New York
– -$1K -187 Closed
3 4 5
6
7

DPLO Hedge Fund Activity: Q3 2019 in Review

137 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q3 2019, worth a combined $317M — down 19% from $391M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new DPLO positions and 17 closed out — a net gain of 6 holders — while 51 added to existing stakes and 35 trimmed.

The largest buyer was Armistice Capital, adding an estimated $12.3M. The largest seller was Deerfield Management, cutting an estimated $22.6M.

  • 137 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q3 2019, up from 131 in Q2 2019.
  • Funds reported $317M of DIPLOMAT PHARMACY, INC. stock for Q3 2019, down 19% quarter-over-quarter.
  • 23 funds opened new DIPLOMAT PHARMACY, INC. positions in Q3 2019 and 17 closed out, a net change of +6 holders.
  • The largest DIPLOMAT PHARMACY, INC. buyer in Q3 2019 was Armistice Capital, an estimated $12.3M added.
  • The largest DIPLOMAT PHARMACY, INC. seller in Q3 2019 was Deerfield Management, an estimated $22.6M sold.

Based on aggregated 13F filings for Q3 2019.